RECRUITING

AnovaOS Network Powered Patient Registry

Description

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

Conditions

Infectious DiseaseNeoplasmsDiseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)Endocrine, Nutritional and Metabolic Diseases (E00-E89)Mental and Behavioural DisordersDiseases of the Nervous SystemDiseases of the Eye and AdnexaDiseases of the Ear and Mastoid ProcessDiseases of the Circulatory SystemDiseases of the Respiratory SystemDiseases of the Digestive SystemDiseases of the Skin and Subcutaneous TissueDiseases of the Musculoskeletal System and Connective TissueDiseases of the Genitourinary SystemPregnancy, Childbirth and the PuerperiumCertain Conditions Originating in the Perinatal PeriodCongenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere ClassifiedInjury, Poisoning and Certain Other Consequences of External CausesExternal Causes of Morbidity and MortalityFactors Influencing Health Status and Contact With Health Services
Talk to us

Related Conditions:

Infectious DiseaseNeoplasmsDiseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)Endocrine, Nutritional and Metabolic Diseases (E00-E89)Mental and Behavioural DisordersDiseases of the Nervous SystemDiseases of the Eye and AdnexaDiseases of the Ear and Mastoid ProcessDiseases of the Circulatory SystemDiseases of the Respiratory SystemDiseases of the Digestive SystemDiseases of the Skin and Subcutaneous TissueDiseases of the Musculoskeletal System and Connective TissueDiseases of the Genitourinary SystemPregnancy, Childbirth and the PuerperiumCertain Conditions Originating in the Perinatal PeriodCongenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere ClassifiedInjury, Poisoning and Certain Other Consequences of External CausesExternal Causes of Morbidity and MortalityFactors Influencing Health Status and Contact With Health Services

Study Overview

On this page

Study Details

Study overview

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

AnovaOS Network Powered Patient Registry

AnovaOS Network Powered Patient Registry

Condition
Infectious Disease
Intervention / Treatment

-

Contacts and Locations

Arlington Heights

Anova Enterprises, Inc., Arlington Heights, Illinois, United States, 60005

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years old or older;
  • * Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
  • * Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
  • * Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
  • * Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
  • * Anticipated additional follow up with the registry once per year.
  • * Subjects who do not meet the inclusion criteria for the study;
  • * Subjects who are unable to understand the protocol or unable to provide legally effective informed consent

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Anova Enterprises, Inc,

Martin Walsh, STUDY_DIRECTOR, Anova Enterprises, Inc

Christopher Beardmore, PRINCIPAL_INVESTIGATOR, Anova Enterprises, Inc

Study Record Dates

2026-08-31